Suppression of human cancer cell proliferation by lipoxygenase inhibitors and gamma-radiation in vitro

General Physiology and Biophysics

Volumn 15, Issue 4, 1996, Pages 317-331

  Hofmanova J ^a   Musilova E ^a   Kozubik A ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

arachidonic acid; cancer cells; cell cycle; gamma radiation; lipoxygenase

Indexed keywords

ARACHIDONIC ACID; ESCULETIN; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; PIROXICAM;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; GAMMA RADIATION; HUMAN; HUMAN CELL; MONOCYTIC LEUKEMIA;

BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE INHIBITORS; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GAMMA RAYS; HUMANS; KINETICS; LIPOXYGENASE INHIBITORS; NORDIHYDROGUAIARETIC ACID; PIROXICAM; THYMIDINE; TUMOR CELLS, CULTURED; UMBELLIFERONES;

EID: 0030504908     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Anderson K. M., Ondrey F., Harris J. E. (1992): ETYA, a pleotropic membrane-active arachidonic acid analogues affects multiple signal transduction pathways in cultured transformed mammalian cells. Clin. Biochem. 25, 1-9
2. Ara G., Teicher B. A. (1996): Cyclooxygenase and lipoxygenase inhibitors in cancer therapy. Prostagland, Leuk. Essent. Fatty A. 54, 3-16
3. Beckerman K. P., Schreiber R. D., Needleman P. (1992): Cytokine modulation of immune activation associated suppression of macrophage Cyclooxygenase activity in vivo. Prostagland. Leuk. Essent. Fatty A. 47, 231-238
4. Di Marzo V. (1995): Arachidonic acid and eicosanoids as targets and effectors in second messenger interaction. Prostagland. Leuk. Essent. Fatty A. 53, 239-254
5. Earnest D. L., Hixson L. J., Alberts D. S. (1992): Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention. J. Cell. Biochem. Suppl. 161, 156-166
6. Fukushima M. (1990): Prostaglandin J2 - anti-tumour and anti-viral activities and the mechanisms involved. Eicosanoids 3, 189-199
7. Fulton A. M. (1984): In vivo effects of indomethacin on the growth of murine mammary tumors. Cancer Res. 44, 2416-2420
8. Furuta Y., Hunter N., Barkley T. Jr., Hall E., Milas L. (1988): Increase in radioresponse of murine tumors by treatment with indomethacin. Cancer Res. 48, 3008-3013
9. Gáti I., Bergström M., Csóka K., Muhr C., Carlsson J. (1990): Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines. Prostagland. Leuk. Essent. Fatty A. 40, 117-123
10. Goodwin J. S., Ceuppens J. L. (1985): Prostaglandins, cellular imunity and cancer. In: Prostaglandins and Immunity (Ed. J. S. Goodwin) pp. 1-34, M. Nijhoff Publ. Boston
11. Honn K. V., Marnett L. J. (1984): Prostaglandin, thromboxane, and leukotriene biosynthesis: target for antitumor and antimetastatic agents. In: Novel Approaches to Cancer Chemotherapy (Ed. P. S. Sunkara) pp. 128-163, Academic Press, Orlando
12. Huang H. CH., Lai M. W., Wang H. R., Chung Y. L., Hsieh L. M., Chen CH. CH. (1993): Antiproliferative effect of esculetin on vascular smooth muscle cells: possible roles of signal transduction pathways. Eur. J. Pharmacol. 237, 39-44
13. Kozubík A., Hofmanová J., Holá J., Netíková J. (1993): The effect of nordihydroguaiaretic acid, an inhibitor of prostaglandin and leukotriene biosynthesis, on hematopoiesis of gamma-irradiated mice. Exp. Hematol. 21, 138-142
14. Kozubík A., Hofmanová J., Pospíšil M., Netíková J., Holá J., Lojek A. (1994): Effects of drugs inhibiting prostaglandin or leukotriene biosynthesis on postirradiation haematopoiesis in mouse. Int. J. Radiat. Biol. 65, 369-377
15. 2 and C. Amer. J. Physiol. 262, C1197-C1203
16. 4 as essential intermediates in CSF-stimulated human myeloid colony formation. Exp. Hematol. 14, 760-765
17. Miller A. M., Sandier E., Kobb S. M., Eastgate J., Zucalli J. (1993): Hematopoietic growth factor induction of gamma-glutamyl transferase in the KG-I myeloid cell line. Exp. Hematol. 21, 9-15
18. Neichi T., Koshihara Y., Murota S. I. (1983): Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim. Biophys. Acta 753, 130-132
19. Noguchi M., Kitagawa H., Miyazaki I., Mizumaki Y. (1993): Influence of esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12 - dimethyl - benz[a]anthracene in rats on high- and low-fat diets. Jpn. J. Cancer Res. 84, 1010-1014
20. 4 production. Cell 69, 295-303
21. Reddy B. S., Tokumo K., Kulkarni N., Aligia C., Kelhoff G. (1992): Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis 13, 1019-1023
22. Rose D. P., Connoly J. M. (1991): Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 18, 243-254
23. Snyder D. S., Castro R., Desforges J. F. (1989): Antiproliferative effects of lipoxygenase inhibitors on malignant human hematopoietic cell lines. Exp. Hematol. 17, 6-9
24. Tang D. G., Chen Y. Q., Honn K. V. (1996): Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. USA 93, 5241-5246
25. Walden T. L. Jr., Farzaneh N. K. (1990): Biological mediators. In: Biochemistry of Ionizing Radiation (Eds. T. L. Walden, Jr. and N. K. Farzaneh) pp. 55-88, Raven Press Ltd, New York
26. Wang Z. Y., Agarwal R., Zhou Z. C., Bickers D. R., Mukhtar H. (1991): Antimutagenic and antitumorigenic activities of nordihydroguaiaretic acid. Mutat. Res. 261, 153-162